These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9063245)

  • 1. Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection.
    Weijtens O; van der Sluijs FA; Schoemaker RC; Lentjes EG; Cohen AF; Romijn FP; van Meurs JC
    Am J Ophthalmol; 1997 Mar; 123(3):358-63. PubMed ID: 9063245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone concentration in vitreous and serum after oral administration.
    Weijtens O; Schoemaker RC; Cohen AF; Romijn FP; Lentjes EG; van Rooij J; van Meurs JC
    Am J Ophthalmol; 1998 May; 125(5):673-9. PubMed ID: 9625551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection.
    Weijtens O; Feron EJ; Schoemaker RC; Cohen AF; Lentjes EG; Romijn FP; van Meurs JC
    Am J Ophthalmol; 1999 Aug; 128(2):192-7. PubMed ID: 10458175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose.
    Weijtens O; Schoemaker RC; Lentjes EG; Romijn FP; Cohen AF; van Meurs JC
    Ophthalmology; 2000 Oct; 107(10):1932-8. PubMed ID: 11013202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate.
    Weijtens O; Schoemaker RC; Romijn FP; Cohen AF; Lentjes EG; van Meurs JC
    Ophthalmology; 2002 Oct; 109(10):1887-91. PubMed ID: 12359610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylprednisolone concentrations in the vitreous and the serum after pulse therapy.
    Behar-Cohen FF; Gauthier S; El Aouni A; Chapon P; Parel JM; Renard G; Chauvaud D
    Retina; 2001; 21(1):48-53. PubMed ID: 11217929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study of vitreous and serum concentrations of triamcinolone acetonide after posterior sub-tenon's injection.
    Kovacs K; Wagley S; Quirk MT; Ceron OM; Silva PA; Singh RJ; Gukasyan HJ; Arroyo JG
    Am J Ophthalmol; 2012 May; 153(5):939-48. PubMed ID: 22310078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study of dexamethasone disodium phosphate using intravitreal, subconjunctival, and intravenous delivery routes in rabbits.
    Hosseini K; Matsushima D; Johnson J; Widera G; Nyam K; Kim L; Xu Y; Yao Y; Cormier M
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):301-8. PubMed ID: 18476800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection.
    Inoue M; Takeda K; Morita K; Yamada M; Tanigawara Y; Oguchi Y
    Am J Ophthalmol; 2004 Dec; 138(6):1046-8. PubMed ID: 15629301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intravitreal dexamethasone on vitreous vancomycin concentrations in patients with suspected postoperative bacterial endophthalmitis.
    Gan IM; Ugahary LC; van Dissel JT; van Meurs JC
    Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1186-9. PubMed ID: 15906066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal triamcinolone acetonide concentration after subtenon injection.
    Thomas ER; Wang J; Ege E; Madsen R; Hainsworth DP
    Am J Ophthalmol; 2006 Nov; 142(5):860-1. PubMed ID: 17056371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal penetration of cefepime after systemic administration to humans.
    Aras C; Ozdamar A; Ozturk R; Karacorlu M; Ozkan S
    Ophthalmologica; 2002; 216(4):261-4. PubMed ID: 12207129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.
    Chang-Lin JE; Attar M; Acheampong AA; Robinson MR; Whitcup SM; Kuppermann BD; Welty D
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):80-6. PubMed ID: 20702826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes.
    Chang-Lin JE; Burke JA; Peng Q; Lin T; Orilla WC; Ghosn CR; Zhang KM; Kuppermann BD; Robinson MR; Whitcup SM; Welty DF
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4605-9. PubMed ID: 21421864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreous levels of active ocriplasmin following intravitreal injection: results of an ascending exposure trial.
    Stalmans P; Girach A
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6620-7. PubMed ID: 23982845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreous concentration of triamcinolone acetonide after a single transseptal depot injection.
    Silva PS; Singh RJ; Bakri SJ; Lising RS; Santiago DE; Uy HS
    Ocul Immunol Inflamm; 2009; 17(3):216-20. PubMed ID: 19585367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular dexamethasone penetration via subconjunctival or retrobulbar injections in rabbits.
    Bodker FS; Ticho BH; Feist RM; Lam TT
    Ophthalmic Surg; 1993 Jul; 24(7):453-7. PubMed ID: 8351091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection.
    Beer PM; Bakri SJ; Singh RJ; Liu W; Peters GB; Miller M
    Ophthalmology; 2003 Apr; 110(4):681-6. PubMed ID: 12689886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular concentrations of chemotherapeutic agents after systemic or local administration.
    Mendelsohn ME; Abramson DH; Madden T; Tong W; Tran HT; Dunkel IJ
    Arch Ophthalmol; 1998 Sep; 116(9):1209-12. PubMed ID: 9747681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization.
    Zhu Q; Ziemssen F; Henke-Fahle S; Tatar O; Szurman P; Aisenbrey S; Schneiderhan-Marra N; Xu X; ; Grisanti S
    Ophthalmology; 2008 Oct; 115(10):1750-5, 1755.e1. PubMed ID: 18708261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.